Arch Pediatr Crit Care Search

CLOSE


Arch Pediatr Crit Care > Volume 3(2); 2025 > Article
Bak and Lee: Current practices of analgosedation in Korean pediatric intensive care units: a nationwide survey

Abstract

Background

Effective pain control and sedation are essential components of pediatric intensive care. Proper analgosedation alleviates discomfort and reduces the risks of under- or over-sedation, withdrawal, and delirium. However, the current state of analgosedation practices in Korean pediatric intensive care units (PICUs) has not been well documented.

Methods

In May 2025, a cross-sectional survey was conducted targeting pediatric intensivists working in Korean PICUs. The survey, distributed by both paper and email, included questions regarding sedation protocols, drug selection, dosing practices, and monitoring tools. Responses were collected from unit-level representatives and analyzed descriptively.

Results

Eighteen PICUs participated in the survey. Half of the units (50%) reported the use of standardized analgosedation protocols, while the other half followed usual care practices. The most frequently used first-line agents were sufentanil (50%) and dexmedetomidine (33.3%). Starting doses for these medications varied among units, ranging from 0.1 to 0.5 μg/kg/hr. Most units reported conducting daily pain and sedation assessments (94.4% and 88.9%, respectively), typically performed multiple times per day by bedside nurses. The Numerical Rating Scale (83.3%) and the Faces, Legs, Activity, Cry, and Consolability scale (77.8%) were the most common tools for pain assessment. Sixteen units utilized validated sedation scales, with the Richmond Agitation-Sedation Scale being the most widely adopted.

Conclusion

This study provides the first national overview of analgosedation practices in Korean PICUs. Substantial variation exists in drug selection, dosing, and assessment strategies. These findings highlight the need for standardized, evidence-based guidelines to ensure consistent and effective sedation management in pediatric critical care settings.

INTRODUCTION

Effective management of pain and agitation is a fundamental component of pediatric intensive care. In critically ill children, the primary goals of analgesia and sedation are to relieve pain, reduce anxiety, and facilitate tolerance of invasive interventions, including mechanical ventilation, at an optimal level of sedation. However, these tasks remain challenging for pediatric intensive care unit (PICU) healthcare providers [1,2]. Therefore, numerous studies, including nationwide surveys, have been conducted to assess current practices and serve as a foundation for the development of evidence-based guidelines aimed at improving clinical implementation [1,3-11].
In recent years, sedation practices have undergone a significant paradigm shift, with increasing emphasis on the concept of “analgosedation.” This approach prioritizes optimal pain control before the administration of sedatives, aiming to minimize sedative-related complications while maintaining patient comfort. The shift reflects growing recognition of the long-term consequences of sedation in pediatric patients and is supported by recent international guidelines. Notably, in 2022, two major consensus-based guidelines on pediatric analgesia and sedation were published, followed by a 2023 summary to assist clinical interpretation and implementation [12-14].
However, in Korea, there are currently no consensus-based guidelines for pediatric analgosedation, and, more importantly, the actual clinical practices remain largely undocumented. Therefore, this study aims to investigate current approaches to analgesia and sedation management in Korean PICUs. The findings are intended to provide a foundational step toward the development of national guidelines and promote standardized, evidence-based care for critically ill children in Korea.

METHODS

This study was approved by the Institutional Review Board of Seoul St. Mary’s Hospital (No. 2025-1671-0001). Patient consent was not applicable.

Study Design

This study employed a cross-sectional design to investigate current practices of analgesia and sedation in PICUs across Korea. The survey was conducted in May 2025. Participants were recruited through the Korean Society of Pediatric Critical Care Medicine and via personal professional networks. For each PICU, at least one pediatric intensivist (typically a unit-based attending) was contacted and invited to participate. The goal was to obtain accurate, unit-level responses from clinicians directly involved in the daily implementation of analgosedation strategies.

Survey Development and Testing

The survey instrument was developed by referencing previously published international guidelines and consensus statements on pediatric analgosedation. Its content and structure were designed to comprehensively capture clinical practices in Korean PICUs while aligning with globally accepted standards. The survey included 21 questions divided into three sections (Supplementary Material 1). The first section collected general information about each PICU, such as unit size and annual patient volume. The second section focused on the medications used for analgesia and sedation, including the use of neuromuscular blocking agents (NMBAs). Respondents were asked to indicate their preferred drugs, the order of preference, initial dosing, and maximum dosing used in clinical practice. The final section addressed the assessment and monitoring of pain and sedation, including the frequency of evaluation, personnel responsible, and validated tools utilized in each unit. To allow for nuanced responses, the survey incorporated single-choice, multiple-choice, and open-ended questions. Survey completion required approximately 15 to 30 minutes.

Data Analysis

All collected data were analyzed descriptively. Categorical variables are summarized as absolute frequencies and percentages. Continuous variables were described using medians and interquartile ranges, reflecting the expected non-normal distribution of most quantitative measures. The results were interpreted to capture the diversity and prevailing trends in sedation practices across Korean PICUs.

RESULTS

Characteristics of Participating PICUs

Among a total of 20 PICU units across 15 hospitals in Korea, survey responses were obtained from 18 units. All but one were exclusively pediatric ICUs; one unit was a mixed adult-pediatric ICU. Except for one, all participating units were affiliated with academic or teaching hospitals. Nine units (50%) reported routinely admitting patients in the early postoperative period following cardiac surgery. Bed capacity and annual patient admissions varied widely among the PICUs, highlighting substantial heterogeneity in both unit size and patient volume (Table 1).

Current Practices of Analgosedation

Nine of the 18 units (50%) reported having an internal protocol for managing analgesia and sedation; however, none reported the use of nurse-driven protocols. Regarding the selection of continuous infusion agents for analgosedation, sufentanil was the most commonly chosen first-line drug (n=8), followed by dexmedetomidine (n=6). The most frequent initial drug combinations for sedation included sufentanil or fentanyl with dexmedetomidine, followed by fentanyl combined with midazolam. Notably, both starting and maximum doses varied substantially across units. In cases of challenging analgosedation, ketamine was the most frequently used adjunctive agent (n=5), followed by chloral hydrate (n=2) (Table 2).

Assessment and Monitoring of Pain and Sedation

All 16 units using prolonged continuous NMBA infusion reported performing monitoring. Additionally, pain and sedation were assessed in 17 and 16 units, respectively (Table 3). The most commonly used tool for pain assessment was the Numerical Rating Scale (NRS; n=15), followed by the Face, Legs, Activity, Cry, Consolability (FLACC) scale (n=14). For sedation assessment, the Richmond Agitation-Sedation Scale (RASS) was used in 14 units. In most units, bedside nurses were primarily responsible for monitoring and documenting analgosedation status. With the exception of one unit, all PICUs conducted pain assessments more than once daily. Some units reported even more frequent assessments depending on clinical context, including at the start of each nursing shift, before and after painful procedures, and following any changes to sedative or analgesic medications or other relevant interventions. These findings demonstrate considerable variability in monitoring practices among institutions.

DISCUSSION

This nationwide survey is the first to investigate current practices of analgesia and sedation management in PICUs across Korea. Although notable inter-unit variability was observed, overall patterns of practice suggest general alignment with international guidelines. Most Korean PICUs reported adopting the "analgosedation" approach, a paradigm shift emphasized in recent international recommendations, in which opioid-based analgesia is initiated prior to the use of sedative agents [12]. In our survey, 11 units identified opioids as their first-line treatment, reflecting this trend. Notably, sufentanil emerged as the most commonly selected first-line opioid among Korean PICUs, differing from a 2022 European survey that ranked fentanyl, morphine, and sufentanil in that order of opioid preference [10]. Regarding sedatives, dexmedetomidine, a selective alpha-2 agonist used for light sedation, was frequently used in Korean PICUs, whereas midazolam remained the predominant choice (66%) in the 2022 European data. Acetaminophen, used for opioid-sparing purposes, and NMBAs, when clinically indicated, were also actively employed. Despite this, there was significant inter-unit variability in drug combinations, dosing strategies, and escalation protocols.
Due to the small sample size (18 units) and structural heterogeneity among the participating PICUs, no clear correlation was identified between unit characteristics and specific analgosedation practices. A substantial number of units reported never using inhaled agents or clonidine, which may reflect limited drug availability in Korea. Propofol, although conditionally recommended in international guidelines for short-term sedation at doses less than 4 mg/kg/hr for up to 48 hours, was not widely used and was never used in seven Korean PICUs, possibly due to safety concerns or institutional policies.
Protocolized sedation and analgesia, which has been shown to improve patient outcomes and is recommended in recent guidelines, was implemented in only half of the surveyed units, and none reported the use of nurse-driven protocols [13,15-21]. Nevertheless, the monitoring, assessment, and documentation of pain and sedation were performed almost exclusively by bedside nurses. This finding highlights the pivotal role of nursing staff in daily sedation management and underscores the importance of involving them in the development of future protocols. Given their continuous presence at the bedside and direct involvement in patient care, nurses are well-positioned to provide valuable, evidence-based insights into appropriate levels of analgosedation. Moreover, prior studies have identified discrepancies in perceptions, barriers, and clinical practices between physicians and nurses. Addressing these differences will be essential for successfully implementing unified, multidisciplinary sedation protocols [22,23].
Furthermore, international guidelines now recommend incorporating nonpharmacologic strategies such as parental involvement, environmental controls, and sleep-preserving interventions to mitigate psychological stress in pediatric ICU patients [13]. While these factors may serve as valuable alternatives to reduce the use of analgosedative drugs, their implementation can be particularly challenging in the Korean context. In contrast to practices in many other countries, 24-hour family presence is generally not permitted, and highly restricted family visitation policies are common in Korean PICUs. Coupled with a low nurse-to-patient ratio, these limitations present substantial barriers to the implementation of light sedation strategies, highlighting notable gap between international recommendations and what is practically feasible in local settings.
International studies have also reported a shift away from minimal sedation practices during the coronavirus disease 2019 (COVID-19) pandemic, attributed to restricted family visitation, increased caregiver stress, and logistical barriers such as the burden of personal protective equipment [24]. These factors were associated with increased sedative use and a departure from previously established child-friendly sedation philosophies. The present study clearly illustrates that analgosedation strategies are influenced not only by clinical factors but also by external elements such as overall ICU practices, environmental conditions, cultural norms, and human resource structures. While these international insights are valuable, this study, as the first of its kind in Korea, does not permit a direct comparison of pre- and post-pandemic sedation practices.
The management of analgosedation in PICUs remains inherently complex, influenced by factors such as patient age, developmental stage, pharmacodynamics and pharmacokinetics, disease severity, staff-to-patient ratios, available medications, and the degree of family involvement [25,26]. In Korea, additional challenges include differences in drug approvals, supply chain issues, and the absence of structured family-centered care models. These variables highlight the urgent need for evidence-based, locally applicable analgosedation guidelines and underscore the importance of ongoing surveillance of clinical practices.
This study has several limitations. First, the survey included only attending pediatric intensivists and did not capture the perspectives of nursing staff, who play a crucial role in continuous bedside care as well as in the assessment and monitoring of pain and sedation. As a result, the study was unable to evaluate potential differences in perceptions or barriers regarding analgosedation between physicians and nurses. Previous research has shown that discrepancies between these professional groups can significantly influence both the implementation and effectiveness of protocolized sedation strategies. Including nurses in future surveys would provide a more comprehensive and accurate understanding of actual bedside practices and challenges. Second, although pediatric delirium has garnered increasing international attention as a critical outcome indicator in intensive care, this study did not assess current delirium monitoring or management practices in Korean PICUs [26,27]. Future research should seek to evaluate existing approaches to delirium screening, prevention, and treatment. Additional topics that warrant further investigation include sedation weaning protocols, validated withdrawal assessment tools, and inter-professional differences in attitudes toward recommended sedation strategies [28,29]. Despite these limitations, this study provides the first national overview of analgosedation practices in Korean PICUs and establishes a valuable foundation for future improvement.
In conclusion, while most units demonstrate alignment with recent international trends, notable inconsistencies remain in drug selection, protocol implementation, and monitoring approaches. The absence of standardized national guidelines and the limited involvement of nursing staff in protocol development highlight key areas for advancement. Moving forward there is a clear need for the development of evidence-based, Korea-specific analgosedation guidelines that not only address the use of analgesic and sedative agents, but also provide structured recommendations for tapering protocols and the assessment and management of iatrogenic withdrawal symptoms. Furthermore, regular monitoring and evaluation of clinical analgosedation practices will be essential to improving the quality, safety, and consistency of sedation management for critically ill pediatric patients.

ARTICLE INFORMATION

Author contributions
Conceptualization: IKL. Methodology: IKL. Formal analysis: IKL. Data curation: YGB, IKL. Visualization: YGB. Project ad­ministration: IKL. Writing - original draft: IKL, YGB. Writing - review & editing: YGB, IKL. All authors read and agreed to the published version of the manuscript.
Conflict of interest
None.
Data availability
Data of this research are available from the corresponding author upon reasonable request.
Acknowledgments
None.

SUPPLEMENTARY MATERIALS

Supplementary materials can be found via https://doi.org/10.32990/apcc.2025.00038.
Supplementary Material 1.
Survey on Pain control and sedation in Korean Pediatric intensive Care units
apcc-2025-00038-Supplementary-Marterial-1.pdf

Table 1.
Characteristics of included PICUs
Characteristics Value
Pediatric 17 (94.4)
 Medico-surgical 9 (50.0)
 Medical 3 (16.7)
 Surgical 2 (11.1)
 Cardiac 1 (5.6)
Adult and pediatric 1 (5.6)
 Medico-surgical 1 (5.6)
Admission of immediate postcardiac surgery 9 (50.0)
Maximum number of available beds 9 (5–13)
  Min–max 2–16
Number of admissions per year, median (IQR) (min–max) 250 (140–700)
  Min–max 17–2,275

Values are presented as number (%) or median (interquartile range) unless otherwise indicated.

PICU, pediatric intensive care unit; IQR, interquartile range.

Table 2.
Analgosedative practice in Korean PICUs
Variable No. (%) Initial dose Maximum dose
Presence of internal protocol for analgesia and sedation 9 (50.0) - -
Use of a nurse driven protocol for analgesia and sedation 9 (50.0) - -
Drug used as first choice for continuous analgosedation
 Sufentanil (μg/kg/hr) 8 (44.4) 0.1–0.5 0.8–1.0
 Dexmedetomidine (μg/kg/hr) 7 (38.9) 0.1–0.5 0.7–2.0
 Fentanyl (μg/kg/hr) 2 (11.1) 0.5–1.0 2.0–5.0
 Remifentanil (μg/kg/min) 1 (5.6) 0.1–0.2 0.3
Drug used as second choice for continuous analgosedation
 Dexmedetomidine (μg/kg/hr) 4 (22.2) 0.1–0.2 0.7–2.0
 Midazolam (mg/kg/hr) 7 (38.9) 0.02–0.1 0.04–0.6
 Fentanyl (μg/kg/hr) 2 (11.1) 0.5–1.0 2.0–4.0
 Sufentanil (μg/kg/hr) 3 (16.7) 0.2–0.5 1.0–2.0
 Ketamine (mg/kg/hr) 2 (11.1) 5.0 20.0
Drug used as first choice for difficult analgosedation
 Ketamine (mg/kg/hr) 5 (27.8) 5.0 20.0
 Chloral hydrate (mL/kg) 2 (11.1) 0.3–0.5 0.5–1.0
 Dexmedetomidine (μg/kg/hr) 2 (11.1) 0.2–0.5 0.7–1.0
 Propofol (mg/kg/hr) 2 (11.1) 1–3 3–5
Drugs never used for continuous analgosedation - -
 Inhaled agents 16 (88.9)
 Clonidine 14 (77.8)
 Anti-psychotics 9 (50.0)
 Propofol 7 (38.9)
 Morphine 7 (38.9)
 Fentanyl 3 (16.7)
 Sufentanil 1 (5.6)
Use of acetaminophen for opioid-sparing purposes 12 (66.7) - -
Use of NMBA continuous infusion 16 (88.9) - -
 Vecuronium 12 (66.7)
 Rocuronium 7 (38.9)

PICU, pediatric intensive care unit; NMBA, neuromuscular blocking agent.

Table 3.
Practices of analgosedation in Korean PICUs
Variable No. (%)
Monitoring scales for NMBA continuous infusion 16 (88.9)
 Vital signs modification 16 (88.9)
 4-Channel processed EEG 4 (22.2)
 Bispectral index 2 (11.1)
 Clinical scale evaluation during daily discontinuation of NMBA 1 (5.6)
Monitoring scales for analgesia 17 (94.4)
 Numerical Rating Scale 15 (83.3)
 FLACC scale 14 (77.8)
 Wong-Baker scale 3 (16.7)
 Others 2 (11.1)
 FPRS 1 (5.6)
Monitoring tools for sedation 16 (88.9)
 Richmond Sedation-Agitation Scale 14 (77.8)
 Vital signs modification 3 (16.7)
 Ramsay Sedation Scale 1 (5.6)
 4-Channel processed EEG 1 (5.6)
 Modified observer's alertness/sedation scale 1 (5.6)

PICU, pediatric intensive care unit; NMBA, neuromuscular blocking agent; EEG, electroencephalogram; FLACC, Faces, Legs, Activity, Cry, and Consolability; FPRS, face pain rating scale.

REFERENCES

1. Egbuta C, Mason KP. Current state of analgesia and sedation in the pediatric intensive care unit. J Clin Med 2021;10:1847.
crossref pmid pmc
2. Bozan G, Koçkuzu E, Korulmaz A, Altuğ Ü, Yıldızdaş D. Sedation-analgesia, muscle relaxant applications in pediatric intensive care units and guidelines for the management and environment optimization of clinical statements such as withdrawal, delirium developed during these applications. J Pediatr Emerg Intensive Care Med 2024;11:57-75.
crossref
3. Kudchadkar SR, Yaster M, Punjabi NM. Sedation, sleep promotion, and delirium screening practices in the care of mechanically ventilated children: a wake-up call for the pediatric critical care community. Crit Care Med 2014;42:1592-600.
crossref pmid pmc
4. Mondardini MC, Vasile B, Amigoni A, Baroncini S, Conio A, Mantovani A, et al. Update of recommendations for Analgosedation in pediatric intensive care unit. Minerva Anestesiol 2014;80:1018-29.
pmid
5. Keogh SJ, Long DA, Horn DV. Practice guidelines for sedation and analgesia management of critically ill children: a pilot study evaluating guideline impact and feasibility in the PICU. BMJ Open 2015;5:e006428.
crossref pmid pmc
6. Harris J, Ramelet AS, van Dijk M, Pokorna P, Wielenga J, Tume L, et al. Clinical recommendations for pain, sedation, withdrawal and delirium assessment in critically ill infants and children: an ESPNIC position statement for healthcare professionals. Intensive Care Med 2016;42:972-86.
crossref pmid pmc pdf
7. Patel AK, Trujillo-Rivera E, Faruqe F, Heneghan JA, Workman TE, Zeng-Treitler Q, et al. Sedation, analgesia, and neuromuscular blockade: an assessment of practices from 2009 to 2016 in a national sample of 66,443 pediatric patients cared for in the ICU. Pediatr Crit Care Med 2020;21:e599-609.
crossref pmid pmc
8. Sauer H, Lobenhofer M, Abdul-Khaliq H. Analgosedation for diagnostic and interventional procedures: a countrywide survey of pediatric centers in Germany. Ital J Pediatr 2020;46:14.
crossref pmid pmc pdf
9. Ekinci F, Yildizdas D, Horoz OO, Aslan N; Society of Pediatric Emergency Intensive Care Medicine of Turkey-Sedoanalgesia Study Group. Sedation and analgesia practices in pediatric intensive care units: a survey of 27 centers from Turkey. J Pediatr Intensive Care 2020;10:289-97.
crossref pmid pmc
10. Daverio M, von Borell F, Ramelet AS, Sperotto F, Pokorna P, Brenner S, et al. Pain and sedation management and monitoring in pediatric intensive care units across Europe: an ESPNIC survey. Crit Care 2022;26:88.
crossref pmid pmc pdf
11. Ista E, Redivo J, Kananur P, Choong K, Colleti J Jr, Needham DM, et al. ABCDEF bundle practices for critically ill children: an international survey of 161 PICUs in 18 countries. Crit Care Med 2022;50:114-25.
crossref pmid
12. Smith HA, Besunder JB, Betters KA, Johnson PN, Srinivasan V, Stormorken A, et al. 2022 Society of Critical Care Medicine Clinical Practice Guidelines on prevention and management of pain, agitation, neuromuscular blockade, and delirium in critically ill pediatric patients with consideration of the ICU environment and early mobility. Pediatr Crit Care Med 2022;23:e74-110.
crossref pmid
13. Mondardini MC, Sperotto F, Daverio M, Amigoni A. Analgesia and sedation in critically ill pediatric patients: an update from the recent guidelines and point of view. Eur J Pediatr 2023;182:2013-26.
crossref pmid pdf
14. Amigoni A, Conti G, Conio A, Corno M, Fazio PC, Ferrero F, et al. Recommendations for analgesia and sedation in critically ill children admitted to intensive care unit. J Anesth Analg Crit Care 2022;2:9.
crossref pmid pmc pdf
15. Taffarel P, Widmer J, Fiore Á, Rodríguez AP, Meregalli C, Jorro Barón F. Impact of the implementation of a sedation and analgesia protocol in a pediatric intensive care unit. Arch Argent Pediatr 2023;121:e202202806.
crossref pmid
16. Yang Y, Geva A, Madden K, Mehta NM. Implementation science in pediatric critical care: sedation and analgesia practices as a case study. Front Pediatr 2022;10:864029.
crossref pmid pmc
17. Shildt N, Traube C, Dealmeida M, Dave I, Gillespie S, Moore W, et al. “Difficult to sedate”: successful implementation of a benzodiazepine-sparing analgosedation-protocol in mechanically ventilated children. Children (Basel) 2021;8:348.
crossref pmid pmc
18. Gaillard-Le Roux B, Liet JM, Bourgoin P, Legrand A, Roze JC, Joram N. Implementation of a nurse-driven sedation protocol in a PICU decreases daily doses of midazolam. Pediatr Crit Care Med 2017;18:e9-17.
crossref pmid
19. Larson GE, McKeever S. Nurse titrated analgesia and sedation in intensive care increases the frequency of comfort assessment and reduces midazolam use in paediatric patients following cardiac surgery. Aust Crit Care 2018;31:31-6.
crossref pmid
20. Hanser A, Neunhoeffer F, Hayer T, Hofbeck M, Schlensak C, Mustafi M, et al. A nurse-driven analgesia and sedation protocol reduces length of PICU stay and cumulative dose of benzodiazepines after corrective surgery for tetralogy of Fallot. J Spec Pediatr Nurs 2020;25:e12291.
crossref pmid pdf
21. Balit CR, LaRosa JM, Ong JS, Kudchadkar SR. Sedation protocols in the pediatric intensive care unit: fact or fiction? Transl Pediatr 2021;10:2814-24.
crossref pmid pmc
22. Kolmar AR, Kerley L, Melliere MG, Fuller BM. Sedation experiences of pediatric intensive care nurses: exploring PICU nurse perspectives on sedative management and communication. J Intensive Care Med 2025;40:60-6.
crossref pmid pdf
23. Sneyers B, Laterre PF, Perreault MM, Wouters D, Spinewine A. Current practices and barriers impairing physicians’ and nurses’ adherence to analgo-sedation recommendations in the intensive care unit: a national survey. Crit Care 2014;18:655.
crossref pmid pmc pdf
24. Pumphrey K, Bouzaher A, Achuff BJ, Traube C. Sedation practices in the PICU: an unexpected casualty of COVID-19. Crit Care Explor 2022;4:e0713.
crossref pmid pmc
25. de Castro RE, Rodríguez-Rubio M, de Magalhães-Barbosa MC, Prata-Barbosa A, Holbrook J, Kamat P, et al. A review of key strategies to address the shortage of analgesics and sedatives in pediatric intensive care. Front Pediatr 2022;10:895541.
crossref pmid pmc
26. Alvarado S, MacDonald I, Chanez V, Kudchadkar SR, Ista E, Ramelet AS. Practices of assessment of pain, sedation, iatrogenic withdrawal syndrome, and delirium in European paediatric intensive care units: a secondary analysis of the European Prevalence of Acute Rehab for Kids in the paediatric intensive care unit study. Aust Crit Care 2025;38:101113.
crossref pmid
27. Bettencourt A, Mullen JE. Delirium in children: identification, prevention, and management. Crit Care Nurse 2017;37:e9-18.
crossref pmid pdf
28. van Dijk M, Ista E. Four-in-one: a comprehensive checklist for the assessment of pain, undersedation, iatrogenic withdrawal and delirium in the PICU: a Delphi study. Front Pediatr 2022;10:887689.
crossref pmid pmc
29. McAlister S, Connor JA, Engstrand S, McLellan MC. Validation of the withdrawal assessment tool-1 (WAT-1) in pediatric cardiovascular patients on an inpatient unit. J Spec Pediatr Nurs 2023;28:e12404.
crossref pmid pdf


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICIES
FOR CONTRIBUTORS
Editorial Office
#1203, 115 Hangang-daero, Yongsan-gu, Seoul 04378, Korea
Tel: +82-2-744-7888    E-mail: office@apccjournal.org                

Copyright © 2026 by Korean Society of Pediatric Critical Care Medicine.

Developed in M2PI

Close layer
prev next